As a part of our research on the synthesis of cephalosporins bearing condensed-heterocyclic azolium groups at the 3 position in the cephalosporin nucleus, we describe herein the synthesis of 
2(Z)
Thus, in an effort to expand the antibacterial spectrum of I, we examined the antibacterial activity of derivatives of I having various substituents at the 5 position in the thiazole ring.
In this paper, we describe the synthesis and the antibacterial activity of 7/?-[2-(2-amino-5-substitutedthiazol-4-yl)-2(Z)-alkoxyiminoacetamido] -3-(condensed-heterocyclic azolium)methyl cephalosporins.
iminoacetate (VI) was treated with sodium thiocyanate and bromine in acetic acid or methanol to give methyl 2-(2-amino-5-thiocyanothiazol-4-yl)-2(Z)-methoxyiminoacetate (VII), which was reacted with sodium borohydride in methanol containing an excess amount of methyl iodide to give methyl 2- ( 
2-amino-5-methylthiothiazol-4-yl)-2(Z)-methoxyiminoacetate (VIII).
The oxidation of VIII with 30% hydrogen peroxide in a mixture of acetic acid and dichloromethane at room temperature afforded methyl 2-(2-amino-5-methylsulfinylthiazol-4-yl)-
2(Z)-methoxyiminoacetate (IX).
Further, methyl 2-(2-amino-5-methylsulfonylthiazol-4-yl)-2(Z)-methoxyiminoacetate (X) was obtained by reacting VIII with an excess amount of 30% hydrogen peroxide at 55°C for 12 hours.
VIII, IX, and X were converted to the corresponding carboxylic acids (III-6~III-8, respectively) by hydrolysis.
Subsequently, the sulfonation of 2-(2-aminothiazol-4-yl)-2(Z)-methoxyiminoacetic acid (II-l) with 30% oleum under ice-cooling for 10 minutes and then at room temperature for one hour afforded 2-(2-amino-5-sulfothiazol-4-yl)-2(Z)-methoxyiminoacetic acid (III-9).
Scheme 2 shows an outline for the preparation of 7j8-[2-(2-amino-5-substituted-thiazol-4-yl)-2(Z)-
acid (III-2 -III-9) was converted with 1 -hydroxybenzotriazole (HOBT) and dicyclohexylcarbodiimide to the HOBTester, which was reacted with 7/^amino-3-(3-oxobutyryloxymethyl)-3-cephem-4-carboxylic acid (7-AACA) to give XI-2~XI-9. 2-(5-Chloro-2-chloroacetamidothiazol-4-yl)-2(Z)-methoxyiminoacetic acid (V) was converted with PC15 to the acid chloride, which was reacted with 7-AACAand gave XI-1 after removal of the chloroacetyl group with sodium Af-methyldithiocarbamate. XI was heated with an excess amount of the condensed-heterocyclic azole and sodium iodide in 50%
aqueous acetonitrile at 50~70°C for 1-3 hours. The reaction mixture was purified by column chromatography on silica gel with aqueous acetone as the eluent, followed by repurification by column chromatography on MCI gel CHP 20P or Amberlite XAD-2to give the objective cephalosporins (1, 4~9, 12-24, XII-10 and XII-ll) in 1 -26% yield.
In the case of the compounds 10 and ll, XII-10 and XII-ll with an R2 of ter/-butoxycarbonyl group on the oxyimino moiety was deprotected with trifluoroacetic acid, and the desired cephalosporins were isolated as the sodium salt.
II -2  R2=Et  II-3  R2=CH2CH2C1  II-4  R2=CH2CO2CMe3  II-5  R2=CMe2CO2CMe3   III-2  -III-5   IV   V   VI  VII  VIII   X   III-6  R^SMe  III-7  R^SOMe  III-8  R^SC^Me   II-l  III-9   488THEJOURNAL OF ANTIBIOTICS   APR-1992   Scheme 2.   Ri  R2   XI-2  Cl  Et  XI-3  Cl  CH2CH2C1  XI-4  Cl  CH2CO2CMe3  XI-5  Cl  CMe2CO2CMe3  XI-6  SMe  Me  XI-7  SOMe  Me  XI-8  SO2Me  Me  XI-9  SO3H  Me   Also, 7£-[2-(2-amino-5-bromo-(and 5- compounds were determined by the standard serial two-fold agar dilution method5). Table 1 shows the MICs of 7j8-[2-amino-5-substituted-thiazol-4-yl)-2(Z)-methoxyiminoacetamido]-3-(imidazo[ l ,2-fl]pyridinium-1 -yl)methyl-3-cephem-4-carboxylates (1~7). The antibacterial activity of 5-halogenated derivatives (1 -3) against Staphylococcus aureus was increased as compared to that of 1-1, whereas the antibacterial activity of 1 -3 against Gram-negative bacteria was decreased markedly. The substitution of the thiazole ring with sulfur derivatives led to reduced antibacterial activity against both Gram-positive and Gram-negative bacteria. Amongthe 5-halogeno- thiazolyl cephalosporins, the chlorine derivative (1) showed the most potent activity against both Grampositive and Pseudomonasaeruginosa including cephalosporin-resistant strains. Table 2 shows the effect of various oxime substituents (R2) on the MIC of 7j8-[2-(2-amino-
The antibacterial activity of the ethyl derivative (8) and the 2-chloroethyl derivative (9) against Staphylococcus aureus and some strains of Pseudomonasaeruginosa was improved as compared to that of 1, whereas the activity against the other Gram-negative bacteria was decreased. Table 4 shows the MICs of the 7j5-
. Among the alkyl derivatives, the 5-methyl derivative (17) showed slightly higher antibacterial activity than 14 against both Gram-positive bacteria and Gram-negative bacteria including Pseudomonas aeruginosa.
The MICsof the cephalosporins having an electron withdrawing group (19, 20 and 21) were lower than those of the 5-chloro derivative (14).
In conclusion, we found that substitution of the thiazole ring with a chlorine atom increased the antibacterial activity against Pseudomonas aeruginosa and MRSA, whereas the activity against the other Gram-negative bacteria was decreased.
Experimental
Melting points were determined using a Yanagimoto micro melting point apparatus and are uncorrected. IR spectra were taken on a Hitachi 215 spectrophotometer, and 1HNMR spectra were recorded on a Varian EM-390 (90 MHz) and HL-100A (100 MHz) spectrometer using tetramethylsilane as the internal or external standard. Organic solvents were dried over anhydro MgSO4, and concentration by evaporation was carried out in vacuo. Columnchromatography was carried out on Kieselgel 60 (Merck Art. No. 7734 or 9385), Sephadex LH-20 (Pharmacia Fine Chemicals), MCI gel CHP 20P (Mitsubishi Chemical) and Amberlite XAD-2(Rohm and Haas). The MIC values were determined by the standard Table 4 . Antibacterial activity
(108cfu/ml) Table 3 . Not tested.
serial 2-fold agar dilution method with Mueller-Hinton agar6). Cefpirome (CPR) was prepared according to the procedure described in the literature5*.
acid (II-4, 6.0 g) and 7V-chlorosuccinimide (NCS, 3.2g) in MeOH(100ml) was kept at 60°C for 2 hours with stirring. The reaction mixture was evaporated, and brine and 5%aq sodiumthiosulfate soln were added to the residue. The mixture was extracted with THFand the extract was dried. The solvent was evaporated, and the residue was triturated with «-hexane to give 6.5 g (89%) of III-4 as a colorless amorphous solid; IR (KBr) 
(II-5, 6.0g) and NCS (2.4g) in MeOH(50ml) was stirred at room temperature for 6 hours. The reaction mixture was evaporated and the residue was dissolved in EtOAc.The organic layer was washed with aq satd NaCl, dried and evaporated to give 5.5 g (82%) of III-5 as pale yellow crystals; IR (KBr) cm" 1 1720, 
acid (IV, 55.4 g) and NCS (32 g) in DMF(100 ml) was stirred at 60°C for one hour. To the reaction mixture was added H2O(1200ml), EtOAc (400ml), methyl ethyl ketone (1200ml) and 5% aq sodium thiosulfate soln (200ml), and the resultant mixture was shaken. The organic layer was separated, washed with aq satd NaCl, dried and evaporated. Mel (28.4g) was added to a solution ofVII (27.2g) in a mixture ofMeOH (300ml) and THF (300ml) with ice-cooling and stirring. After the addition was complete, NaBH4 (7.6g) was added portionwise to the reaction mixture which was stirred at roomtemperature for 30 minutes. The reaction mixture was evaporated and the residue was crystallized from H2O to give 24. 
H2O2 (30%, 3.0ml) was added to a solution ofVIII (7.84g) in a mixture ofAcOH (15ml) and CH2C12 (15 ml). After stirring at 50°C for 4 hours, 5% aq sodium hydrogen sulfate soln was added to the reaction mixture to decompose the excess H2O2. The mixture was evaporated and the residue was diluted with H2O. H2O2 (30%, 7.0ml) was added to a solution ofVIII (7.84g) in a mixture ofCH2C12 (30ml) and AcOH (60ml). After the mixture was stirred at room temperature for 10 minutes, at 50°C for one hour and at 55°C for 12 hours. 10%Sodium hydrogen sulfate soln was added to the mixture. The solvent was evaporated APR. 1992 and the residue was suspended in cold H2O. 2-(2-Amino-5-methylthiothiazol-4-yl)-2(Z)-methoxyiminoacetic Acid (HI-6) A solution ofVIII (7.84g) in a mixture of MeOH(30ml) and 4n NaOH(30ml) was stirred at room temperature for 30 minutes and then at 50°C for 15 minutes. 4n HC1 (30ml) was added to the reaction mixture with ice-cooling and the MeOHwas removed by evaporation. The residue was cooled and the precipitate was collected by filtration to give 7.09g (96%) of III-6 as colorless crystals; MP 126~130°C (dec); IR (KBr) cm"1 1650, 1620, 1585 
2-(2-Amino-5-methylsulfinylthiazol-4-yl)-2(Z)-methoxyiminoacetic
Acid (III-7) A solution of IX (7.88g) in a mixture of MeOH(60ml) and 4n NaOH(30ml) was stirred at room temperature for 10 minutes. 4n HC1 (30ml) was added to the reaction mixture with ice-cooling. The solvent was evaporated and the residue was extracted with MeOH. The extract was evaporated and the residue was triturated with Et2O. 
2-(2-Amino-5-methylsulfonylthiazol-4-yl)-2(Z)-methoxyiminoacetic
Acid (III-8) A solution of X (5.4g) in a mixture of MeOH(60ml) and 4n NaOH (20ml) was stirred at room temperature for 30 minutes. 4n HC1 (20 ml) was added to the reaction mixture which was then lyophilized. The residue was extracted with MeOHand the extract was evaporated. The residue was triturated with Et2O to give 3.56g (69%) ofIII-8 as an amorphous solid; IR (KBr) cm"1 1620, 1510, 1310, 1135, 1050; XH NMR (DMSO-J6) 8 3.36 (3H, s), 3 
2-(2-Amino-5-sulfothiazol-4-yl)-2(Z)-methoxyiminoacetic Acid (III-9) 2-(2-Aminothiazol-4-yl)-2(Z)-methoxyiminoacetic
acid (II-1, 6.0 g) was added portionwise to 30% oleum (20 ml) over 10 minutes with stirring at 5°C. The mixture was stirred with ice-cooling for 10 minutes and then at roomtemperature for one hour to give a clear solution. The reaction mixture was poured into a mixture of NaHCO3 (80 g), cold H2O (400ml) and EtOAc (100ml) with stirring and cooling. After removal of the solvent, the residue was extracted with MeOHand the extract was evaporated. The residue was crystallized from H2O to give 4.2g (58%) of III-9 as colorless crystals; MP 190~193°C; IR (KBr) 3 g ) was added to the reaction mixture and then stirred at 40°C for one hour. EtOAc (200ml) was added to the reaction mixture and the mixture was neutralized with concHCl. The aqueous layer was separated and washed with EtOAc. The insoluble precipitate was filtered off and the filtrate was acidified to pH 2.0 with coneHC1 with ice-cooling. After removal of the upper layer of the mixture by decantation, H2O(30ml) was added to the gummyresidue and the mixture was allowed to stand in a refrigerator. 
iV,Af-Dicyclohexylcarbodiimide (DCC, 4.95g) was added to a solution of III-6 (4.95g) and 1-hydroxybenzotriazole hydrate (HOBT, 3.68 g) in DMF(25 ml) with ice-cooling. The mixture was stirred at 5°C for 10 minutes and then at room temperature for one hour. A solution of 7-AACA(6.28g) and triethylamine (4.44g) in DMF(25ml) was added dropwise to the reaction mixture which was stirred at room temperature for 5 hours. The solid was filtered off and Et2O was added to the filtrate. The mixture was cooled and the upper layer was discarded. The residue was dissolved in 5%aq triethylamine (100ml) and concentrated to half volume. The residual solution was acidified to pH 3.0 with 4 n HC1with ice-cooling, and the precipitate was collected by filtration and then dried to give 7.7 g (71%) of XI-6 as an amorphous (2H, br), 9.40 (1H, d, /=8Hz ).
Acid (XI-4) DCC (4.4g) was added to a solution ofIII-4 (6.0g) and HOBT (3.8 g) in DMF (25 ml) and the reaction mixture was stirred with ice-cooling for 5 minutes and then at room temperature for 30 minutes. A solution of 7-AACA (5.61 g) and triethylamine (7.5 ml) in DMF(20ml) was added to the mixture and the resulting solution was stirred at room temperature for 16 hours. The solid was filtered off and Et2O (500ml) was added to the filtrate.
The upper layer was decantated off, and H2O (100ml), EtOAc (200ml) and methyl ethyl ketone (200ml) were added to the residue. The mixture was adjusted to pH 2.5 with concHCl and the solid was filtered off. The organic layer was separated, washed with aq satd NaCl, dried and evaporated to give 10.1 g (89%) ofXI-4 as an amorphous solid; IR (KBr) cm"x 1780, 1740, 1620; XH NMR(DMSO-d6) S 1.44 (9H, s), 2.10 (3H, s), 3.42 and 3.64 (2H, ABq, /=18Hz), 3.64 (2H, s), 4.57 (2H, s), 4.79 and 5.08 (2H,ABq,/= 13Hz), 5.14(1H,d,/=5Hz), 5.84(1H,dd,/=5and8Hz),7.8(2H,br),9.41
DCC (4.95g) was added to a solution of III-9 (2.99g) and HOBT (3.68g) in DMF(25ml) with ice-cooling, and the resulting mixture was stirred at room temperature for 2 hours. Asolution of 7-AACA (6.28 g) and triethylamine (4.4g) in DMF(25ml) was added to the mixture, and the resulting solution was then stirred at room temperature for 5 hours. The solid was filtered off and Et2O (300ml) was added to the filtrate. The upper layer was decantated off and the residue was triturated with Et2O. The solid was collected by filtration and dissolved in H2O(10ml). The solution was adjusted to pH 1 with 4n HC1and chromatographed on MCI gel CHP20P with 0.01 n HC1 as the eluent. The fraction eluted with 30% aqEtOH was lyophilized to afford 4.0g (69%) of XI-9; XH NMR(DMSO-d6) 3 
(2.0g) and Nal (4.0g) in 50% aqMeCN (20ml) was kept at 70°C for 1.5 hours with stirring. After cooling, the mixture was chromatographed on silica gel with Me2COand aqMe2COas the eluents. The fractions containing the objective compoundwere combined and concentrated, and the residual solution was purified by MCI gel CHP 20P column chromatography with H2Oand aq EtOH as the eluents. The fractions containing the objective compound were combined, concentrated and lyophilized to give 210mg (1 1%) of 4. The analytical results are shown in Tables 5 and 6 .
The cephalosporins 1, 5, 6, 8, 9, 12~24 were prepared by a procedure similar to that mentioned above, and the analytical results are shownin Tables 5 and 6 . solution was acidified to pH 1 with coneHC1. The resulting solution was chromatographed on MCIgel CHP20P with 0.01 n HC1 and 10% EtOH -0.01 n HC1 as the eluents. The fractions containing the objective compoundwere combined and concentrated, and the residual solution was adjusted to pH 7.5 with NaHCO3.The resulting solution was chromatographed on Sephadex LH-20 with H2O. The fractions containing the objective compound were combined, concentrated and lyophilized to give 7 (13%) as an amorphous solid. The analytical data are shown in Tables 5 and 6 .
acid (XI-4, 3.0 g), imiadzo[ l ,2-a]pyridine (3.0 g) and Nal (3.0g) in 50% aqMeCN (20ml) was heated at 70°C for 1.5 hours with stirring. After cooling, the reaction mixture was chromatographed on silica gel with aqMeCN as the eluent. The fractions containing the objective compound were combined and concentrated, and the residual solution was chromatographed on Sephadex LH-20 with H2Oas the eluent. The fractions containing the objective cephalosporin were combined, concentrated and lyophilized to give 0. b) XII-10 (0.28 g) was stirred with TFA(10ml) at room temperature for one hour. After evaporation, Tables 5 and 6 (1-1, 0.40 g) in DMA (4ml) with ice-cooling, and the mixture was stirred at room temperature for 2 hours. Et2O (100ml) was added to the reaction mixture, and the upper layer was decanted off. The residue was triturated with Et2O and the solid was collected by filtration.
The solid was dissolved in 50% aq MeCNand chromatographed on silica gel with aq Me2COas the eluent. The fraction eluted with 75%aqMe2COwas concentrated and the residual solution was chromatographed on Sephadex LH-20with H2Oas the eluent. The fractions containing the objective compound were combined, concentrated and lyophilized to give 0. 19 g (40%) of 2 as an amorphoussolid. The analytical results are shown in Tables 5 and 6. ,2-fl]pyridinium-1 -yl)methyl-3-cephem-4-carboxylate (3) 3 was prepared from 1-1 and AModosuccinimide (NIS) following a procedure similar to that of 2. The analytical results are shownin Tables 5 and 6. 
